<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38560433</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Long COVID outcomes following omicron wave in non-hospital population.</ArticleTitle><Pagination><StartPage>1377866</StartPage><MedlinePgn>1377866</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1377866</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1377866</ELocationID><Abstract><AbstractText Label="BACKGROUND">The persistence of symptoms or the development of new symptoms following a diagnosis of SARS-CoV-2 has given rise to a multifaceted clinical condition referred to as "long COVID" (LC). The understanding of LC among China's non-hospitalized population continues to be insufficient. This investigation was designed to evaluate the protracted consequences amongst this demographic, as well as to identify the associated risk factors.</AbstractText><AbstractText Label="METHODS">This research constitutes a prospective cohort study focusing on non-hospitalized individuals, aged between 18 and 59, who have been positively diagnosed with COVID-19. Each participant was subjected to a sequence of questionnaire-based surveys, designed to evaluate symptoms as well as the status of depression and anxiety. A logistic regression model, adjusted for multiple variables, was employed to scrutinize the correlation between demographic elements, lifestyle attributes, and health-related risk factors in relation to conditions and symptoms post COVID-19 infection.</AbstractText><AbstractText Label="RESULTS">A total of 706 individuals participated in the 3&#x2009;months follow-up, with 620 continuing on to the 6&#x2009;months follow-up. The median age was 35 (28, 43) years, and 597 (85%) are female. Upon follow-up, Compared with patients without LC, patients with LC have a higher proportion of females (420 (87%) vs. 177 (79%); <i>p</i>&#x2009;=&#x2009;0.010), were older (35 (29, 44) years vs. 33 (27, 41) years; <i>p</i>&#x2009;=&#x2009;0.010) and have more comorbidities. Out of all participants, 483 (68.4%) reported experiencing at least one symptom at the 3&#x2009;months mark, while 49.7% reported symptoms persisting at the 6&#x2009;months mark. At the 3&#x2009;months follow-up, the most prevalent persistent symptoms were cough (46%), fatigue (38%), and shortness of breath (34%). By the 6&#x2009;months follow-up, fatigue (25%), shortness of breath (22%), and sleep disorders (16%) were the most commonly reported symptoms. Anxiety and depression were consistently reported as prevalent symptoms throughout the follow-up period. Most patient symptoms fade over time, with the quickest decreases observed in cough (from 46 to 9%), expectoration (from 26 to 6.3%), smell disorder (from 16 to 3.9%), and taste disorder (from 18 to 3.5%). Male and those possessing advanced educational qualifications exhibit a decreased susceptibility to the sustained incidence of coughing. Conversely, older age and the presence of comorbidities were identified as risk factors for persistent fatigue and shortness of breath.</AbstractText><AbstractText Label="CONCLUSION">In the after of COVID-19, it has been observed that the majority of patient symptoms tend to decrease over time. The primary residual symptoms noticed after a 6&#x2009;month follow-up were fatigue, dyspnea, and sleep disturbances. However, it's noteworthy that the risk factors associated with these symptoms exhibit subtle variations. Furthermore, psychological sequelae, namely depression and anxiety, are frequently reported among COVID-19 survivors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Ruiyin, Qi, Tingting, Yuqin, Yan and Kun.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ruiyin</LastName><ForeName>Wang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Beijing Longfu Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Beijing Longfu Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tingting</LastName><ForeName>Wang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Beijing Longfu Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuqin</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Beijing Longfu Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Beijing Longfu Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kun</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Office of the Hospital, Beijing Longfu Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">non-hospital population</Keyword><Keyword MajorTopicYN="N">omicron</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>17</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38560433</ArticleId><ArticleId IdType="pmc">PMC10978792</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1377866</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence (NICE) . COVID-19 rapid guideline: managing the long-term effects of COVID-19. (2020). Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE. Available at: https://www.nice.org.uk/guidance/ng188</Citation></Reference><Reference><Citation>Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, et al. . A systematic review and meta-analysis of long COVID symptoms. Syst Rev. (2023) 12:88. doi: 10.1186/s13643-023-02250-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziolos N, Ioannou P, Baliou S, Kofteridis DP. Long COVID-19 pathophysiology: what do we know so far? Microorganisms. (2023) 11:2458. doi: 10.3390/microorganisms11102458, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11102458</ArticleId><ArticleId IdType="pmc">PMC10609046</ArticleId><ArticleId IdType="pubmed">37894116</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Mccorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. (2022) 55:101762. doi: 10.1016/j.eclinm.2022.101762, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierre V, Draica F, Di Fusco M, Yang J, Nunez-Gonzalez S, Kamar J, et al. . The impact of vaccination and outpatient treatment on the economic burden of COVID-19 in the United States omicron era: a systematic literature review. J Med Econ. (2023) 26:1519&#x2013;31. doi: 10.1080/13696998.2023.2281882</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13696998.2023.2281882</ArticleId><ArticleId IdType="pubmed">37964554</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Roy P, Ravichandran M, Mandal S, Pal D, et al. . Long COVID following omicron wave in eastern India&#x2014;a retrospective cohort study. J Med Virol. (2022) 95:e28214. doi: 10.1002/jmv.28214, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28214</ArticleId><ArticleId IdType="pmc">PMC9874641</ArticleId><ArticleId IdType="pubmed">36224705</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-cov-2. Lancet. (2022) 399:2263&#x2013;4. doi: 10.1016/s0140-6736(22)00941-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health. (2021) 6:e005427. doi: 10.1136/bmjgh-2021-005427, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, et al. . Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med. (2022) 11:61541. doi: 10.3390/jcm11061541, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, et al. . Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. (2021) 51:1107&#x2013;20. doi: 10.1111/cea.13997, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N, Peli E, Calza S, Rodella F, Novelli MP, Cella A, et al. . Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ards. Thorax. (2022) 77:300&#x2013;3. doi: 10.1136/thoraxjnl-2021-218064</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218064</ArticleId><ArticleId IdType="pubmed">34588274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorent N, Vande Weygaerde Y, Claeys E, Guler Caamano Fajardo I, De Vos N, De Wever W, et al. . Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge. ERJ Open Res. (2022) 8:2022. doi: 10.1183/23120541.00004-2022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00004-2022</ArticleId><ArticleId IdType="pmc">PMC8994962</ArticleId><ArticleId IdType="pubmed">35415186</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjenberg Z, Leng S, Tascini C, Garg M, Misso K, El Guerche SC, et al. . Risk of long COVID main symptoms after SARS-cov-2 infection: a systematic review and meta-analysis. Sci Rep-Uk. (2023) 13:15332. doi: 10.1038/s41598-023-42321-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="pubmed">37714919</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas FA, Michael M, Bo Z, Hussein A, Aristo V. Brain-targeted autoimmunity is strongly associated with long COVID and its chronic fatigue syndrome as well as its affective symptoms. Psychiatr Clin Psychol. (2023):e6554. doi: 10.1101/2023.10.04.23296554</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.10.04.23296554</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom A, Emanuel W, Oliver B, Andreas H, Rebekka R, Franziska L, et al. . Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. Acta Neuropathol Com. (2023) 11:1662. doi: 10.1186/s40478-023-01662-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-023-01662-2</ArticleId><ArticleId IdType="pmc">PMC10704838</ArticleId><ArticleId IdType="pubmed">38066589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronstein-Wiedemann R, Tausche K, Kolditz M, Teichert M, Thiel J, Koschel D, et al. . Long-COVID is associated with impaired red blood cell function. Horm Metab Res. (2023) 26:8108. doi: 10.1055/a-2186-8108, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-2186-8108</ArticleId><ArticleId IdType="pubmed">37890507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivantsov K, Lim V, Kukes I, Ternovoy K, Khripunova O. Fatigue in patients with long COVID. Georgian Med News. (2023) 342:108&#x2013;12. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">37991964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y, Otsuka Y, Tokumasu K, Sunada N, Nakano Y, Honda H, et al. . Utility of serum ferritin for predicting myalgic encephalomyelitis/chronic fatigue syndrome in patients with long COVID. J Clin Med. (2023) 12:144737. doi: 10.3390/jcm12144737, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12144737</ArticleId><ArticleId IdType="pmc">PMC10381392</ArticleId><ArticleId IdType="pubmed">37510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccarone MC, Coraci D, Regazzo G, Sarandria N, Scanu A, Masiero S. Evolution of musculoskeletal symptoms in long COVID syndrome: a lexical analysis to approach requirements for an interdisciplinary management. Joint Bone Spine. (2023) 91:105623. doi: 10.1016/j.jbspin.2023.105623, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2023.105623</ArticleId><ArticleId IdType="pubmed">37487957</ArticleId></ArticleIdList></Reference><Reference><Citation>Luca C, Marcella M, Donatella S, Alice T, Fabrizio MG, Alberto M, et al. . A multi-center study investigating long COVID-19 in healthcare workers from North-Eastern Italy: prevalence, risk factors and the impact of pre-existing humoral immunity&#x2014;orchestra project. Vaccine. (2023) 11:21769. doi: 10.3390/vaccines11121769</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11121769</ArticleId><ArticleId IdType="pmc">PMC10747427</ArticleId><ArticleId IdType="pubmed">38140174</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, Mccorkell L, Wei H, Low RJ, Re Em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Infect Diseases. (2021) 24:8802. doi: 10.1101/2020.12.24.20248802</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. . Risk factors for post-COVID-19 condition in previously hospitalised children using the isaric global follow-up protocol: a prospective cohort study. Eur Respir J. (2022) 59:2101341. doi: 10.1183/13993003.01341-2021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Perret JL, Chang AB, Idrose NS, Bui DS, Lowe AJ, et al. . Risk factors for chronic cough in adults: a systematic review and meta-analysis. Respirology. (2021) 27:36&#x2013;47. doi: 10.1111/resp.14169, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14169</ArticleId><ArticleId IdType="pubmed">34658107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavalcikova-Bogdanova N, Buday T, Plevkova J, Song WJ. Chronic cough as a female gender issue. Adv Exp Med Biol. (2016) 84:e182. doi: 10.1007/5584_2015_182</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2015_182</ArticleId><ArticleId IdType="pubmed">26747066</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajek A, Neumann-B&#xf6;hme S, Sabat I, Torbica A, Schrey&#xf6;gg J, Barros PP, et al. . Depression and anxiety in later COVID-19 waves across Europe: new evidence from the European COVID survey (ECOS). Psychiatry Res. (2022) 317:114902. doi: 10.1016/j.psychres.2022.114902, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114902</ArticleId><ArticleId IdType="pmc">PMC9576549</ArticleId><ArticleId IdType="pubmed">37732851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudenstine S, Schulder T, Bhatt KJ, Mcneal K, Ettman CK, Galea S. Long-COVID and comorbid depression and anxiety two years into the COVID-19 pandemic. Psychiatry Res. (2022) 317:114924. doi: 10.1016/j.psychres.2022.114924, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114924</ArticleId><ArticleId IdType="pmc">PMC9597528</ArticleId><ArticleId IdType="pubmed">37732865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaouali F, Chaouch A, Boubaker F, Bouchareb S, Mrabet HE, Ben Mabouk A, et al. . Organic and psychiatric symptoms of &#x201c;long COVID&#x201d; among tunisian patients: a cross sectional study. Eur Psychiatry. (2023) 66:S215&#x2013;6. doi: 10.1192/j.eurpsy.2023.504</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/j.eurpsy.2023.504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirotiak Z, Thomas EBK, Brellenthin AG. Stress, anxiety, and depression severity among individuals with no history, previous history, or current history of long COVID. J Psychosom Res. (2023) 175:111519. doi: 10.1016/j.jpsychores.2023.111519, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111519</ArticleId><ArticleId IdType="pubmed">37832276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone D, Tassinari A, Valentinotti R, Kontogiannis D, Ronchese F, Centonze S, et al. . Persistence of symptoms 15 months since COVID-19 diagnosis: prevalence, risk factors and residual work ability. Life. (2022) 13:e97. doi: 10.3390/life13010097, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13010097</ArticleId><ArticleId IdType="pmc">PMC9862952</ArticleId><ArticleId IdType="pubmed">36676046</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>